Evaluation of response to enzalutamide consecutively after disease progression on abiraterone prednisone
Dr. Petros Grivas, MD at Cleveland Clinic discusses the evaluation of response to enzalutamide consecutively after disease progression on abiraterone prednisone at ASCO GU 2016 in San Francisco.
Author: 2016_Genitourinary
Added: 01/08/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Prednisone